Today: 17 January 2026
Subscribe
Browse Category

Cannabis Industry News 4 November 2025 - 12 December 2025

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

December 12, 2025 — Cronos Group Inc. (NASDAQ: CRON , TSX: CRON ) is back in the spotlight after cannabis stocks jumped broadly into early trading on reports that the Trump administration could pursue a major easing of federal marijuana restrictions — specifically, a push to reclassify marijuana from Schedule I to Schedule III . Reuters For Cronos investors, today’s…
12 December 2025
···
Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation stock (NASDAQ: CGC ; TSX: WEED ) is in the spotlight on Friday, December 12, 2025 , after a fresh wave of US federal policy speculation sent cannabis names sharply higher in premarket trading. The immediate catalyst: a report that President Donald Trump is expected to push for a major easing of federal marijuana restrictions—specifically, directing agencies…
12 December 2025
····
Tilray Brands (TLRY) Stock Jumps on Trump Marijuana Rescheduling Report: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Tilray Brands (TLRY) Stock Jumps on Trump Marijuana Rescheduling Report: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Tilray Brands (NASDAQ: TLRY) is surging as cannabis stocks rally on fresh U.S. rescheduling headlines. Here’s what’s driving TLRY, what analysts forecast, and what to watch next. Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) is back in the spotlight on Friday, December 12, 2025, after a sharp move higher in extended-hours trading and premarket action alongside a broader rally in…
12 December 2025
····
US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

Updated: Friday, December 12, 2025 — 6:00 a.m. ET SEO summary: Here are the biggest US stock market premarket gainers today (NYSE/Nasdaq) and the news driving them, including Lululemon’s earnings and CEO transition, a cannabis-stock surge tied to marijuana rescheduling headlines, and earnings-driven jumps in Mitek and Quanex.  Nasdaq US stock futures were mixed early Friday, with investors balancing a post-Fed backdrop against renewed questions around big-tech AI spending after Oracle’s latest move and…
12 December 2025
···
Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

As of December 10, 2025 Tilray stock rebounds 12% after brutal selling Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) just reminded investors how violently cannabis stocks can move. On Tuesday, December 9, 2025, TLRY jumped about 12.4% to close around $8.09, sharply outperforming a flat broader market. Trading volume topped 8.6 million shares, above the 50‑day average of roughly 7.8…
10 December 2025
····
Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis Inc. (NASDAQ: ACB; TSX: ACB) is ending 2025 in a very different place from where it started. After years of restructuring, the company has become a highly focused global medical cannabis business, with new partnerships in Australia, expanding operations in Europe, and back‑to‑back quarters of record medical revenue. As of the latest trading sessions before December 7, 2025,…
7 December 2025
····
Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

December 6, 2025 Canopy Growth Stock Snapshot as of December 6, 2025 Canopy Growth Corp (NASDAQ: CGC, TSX: WEED) remains one of the most volatile names in global cannabis — and 2025 has been no exception. In other words, CGC is bouncing off its lows but still priced like a distressed turnaround. Q2 FY2026 Earnings: Margins Improve, Losses Narrow Canopy’s…
6 December 2025
····
Tilray Stock Today, November 23, 2025: TLRY Under $1 as AI Trading Signals, Hemp Rules and Big Holders Collide

Tilray Stock Today, November 23, 2025: TLRY Under $1 as AI Trading Signals, Hemp Rules and Big Holders Collide

Tilray Brands stock (NASDAQ: TLRY; TSX: TLRY) is back in the spotlight this Sunday, November 23, 2025, for all the reasons that make cannabis names both fascinating and stressful to follow:the share price has slipped back under $1, new AI-driven trading plans dropped this morning, a fresh “millionaire maker” think-piece is circulating, and regulators are pulling the sector in opposite…
23 November 2025
····
Tilray Brands (TLRY) on November 23, 2025: Stock Under $1, Fresh AI Trading Signals, and a Tug-of-War Between Fundamentals and Regulation

Tilray Brands (TLRY) on November 23, 2025: Stock Under $1, Fresh AI Trading Signals, and a Tug-of-War Between Fundamentals and Regulation

Published: November 23, 2025 Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) is back in focus today as new AI-driven trading signals, updated valuation models, and recent analyst forecasts collide with a volatile share price that’s again trading under $1. TLRY stock today: trading under $1 after a bruising week As of this weekend, Tilray Brands’ U.S.-listed stock is trading around…
23 November 2025
··
Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. (NASDAQ: AKAN) is back in the news today after outlining the next steps toward a full Health Canada cultivation license at its British Columbia cannabis site, while commentators highlight the company’s unusual mix of Mexican telecom infrastructure and Canadian cannabis “optionality.” Newsfile A fresh Newsfile press release this morning details how Akanda will design and implement Health Canada–compliant…
14 November 2025
·
Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth Corporation (NASDAQ: CGC; TSX: WEED) reported second‑quarter fiscal 2026 results today that highlight improving operations, tighter cost control, and a stronger balance sheet. The company ended the quarter with C$298 million in cash and cash equivalents, exceeding total debt by C$70 million—and said the conditions that had previously raised “substantial doubt” about its ability to continue as a…
7 November 2025
···
SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. (NASDAQ: SNDL), one of Canada’s largest cannabis and liquor retailers, just released its third-quarter 2025 results, sending its stock price tumbling. Below is a summary of key facts, followed by an in-depth analysis of the latest news, financials, expert opinions, forecasts, and how SNDL compares to peers in the cannabis sector. Recent News and Developments (Late Oct –…
4 November 2025
···
1 2 3

Stock Market Today

  • Bank of Hawaii valuation: momentum tests fair value near price
    January 17, 2026, 1:00 PM EST. Bank of Hawaii trades at $71.25, with an intrinsic value of about $74, implying a 44.6% discount to the stated fair value and a near-term upside of roughly 3.9%. A recent price move left the stock up 0.85% on the day, while 90-day returns of about 16.6% contrast with a 1-year total shareholder return near 4.2%. Analysts model revenue rising about 9% a year over the next three years, supported by margins that could lift earnings multiples for banks. The bear case rests on Hawaii's real estate cycle and higher funding costs that could compress net interest margins. The full narrative walks through earnings paths, valuation math, and the assumptions behind the $74 fair value. Investors can adjust the thesis with Do it your way or screen for other opportunities.
Go toTop